Silver nano-particles are known to provide antimicrobial properties in medical textiles. They can be incorporated into medical textiles in two ways. By having them introduced into the polymer during the yarn production itself OR after the textile fabrication , ie. loaded as entrapped particles during the yarn bundling, weaving or knitting process. Which one of them is a preferred practice from the manufacturing as well as efficacy point of view?